Skip Navigation

VAERS Bibliography - April 2008

1. Immunization Information Systems Progress--United States, 2006. MMWR Morb Mortal Wkly Rep; 57 (11): 289-291; March 21, 2008.

2. U.S.-Incurred Costs of Wild Poliovirus Infections in a Camp With U.S.-Bound Refugees--Kenya, 2006. MMWR Morb Mortal Wkly Rep; 57 (9): 232-235; March 7, 2008.

3. Cost of Vaccinating Refugees Overseas Versus After Arrival in the United States, 2005. MMWR Morb Mortal Wkly Rep; 57 (9): 229-232; March 7, 2008.

4. Fifteen Infectious Diseases Have Been Enrolled in the National Immunization Drive. Chin Med J (Engl ); 121 (6): 565; March, 2008.

5. Abramson, J. S.; Almquist, J. R.; Jenkins, R. R.; Bocchini, J. A., Jr.; Davis, R. M.; Langston, E. L.; Hale, R. W.; Gall, S. A. Prioritisation of Routine Vaccines: a Mistake for the USA. Lancet; 371 (9616): 881-882; March 15, 2008.

6. Adamkiewicz, T. V.; Silk, B. J.; Howgate, J.; Baughman, W.; Strayhorn, G.; Sullivan, K.; Farley, M. M. Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease in the First Decade of Life. Pediatrics; 121 (3): 562-569; March, 2008.

7. Andrus, J. K.; Crouch, A. A.; Fitzsimmons, J.; Vicari, A.; Tambini, G. Immunization and the Millennium Development Goals: Progress and Challenges in Latin America and the Caribbean. Health Aff (Millwood ); 27 (2): 487-493; March, 2008.

8. Aremi-Williams, R. I.; Igwilo, C. I. Community Pharmacies As Possible Centres for Routine Immunization. Nig Q J Hosp Med; 17 (4): 131-133; October, 2007.

9. Atrasheuskaya, A. V.; Kulak, M. V.; Neverov, A. A.; Rubin, S.; Ignatyev, G. M. Measles Cases in Highly Vaccinated Population of Novosibirsk, Russia, 2000-2005. Vaccine; February 27, 2008. [Epub ahead of print].

10. Bair, R. M.; Mays, R. M.; Sturm, L. A.; Perkins, S. M.; Juliar, B. E.; Zimet, G. D. Acceptability to Latino Parents of Sexually Transmitted Infection Vaccination. Ambul Pediatr; 8 (2): 98-103; March 17, 2008.

11. Brauchli, Y. B.; Gittermann, M.; Michot, M.; Krahenbuhl, S.; Gnehm, H. E. A FATAL TICK BITE OCCURRING DURING THE COURSE OF TICK-BORNE ENCEPHALITIS VACCINATION. Pediatr Infect Dis J; 27(4):363-365. April, 2008.

12. Braun, M. M. Toward Better Vaccine Safety Data and Safer Vaccination. Pediatrics; 121 (3): 625-626; March, 2008. VAERS

13. Chapman, L. E.; Iskander, J. K.; Chen, R. T.; Neff, J.; Birkhead, G. S.; Poland, G.; Gray, G. C.; Siegel, J.; Sepkowitz, K.; Robertson, R. M.; Yancy, C.; Guerra, F. A.; Gardner, P.; Modlin, J. F.; Maurer, T.; Berger, T.; Flanders, W. D.; Shope, R. A Process for Sentinel Case Review to Assess Causal Relationships Between Smallpox Vaccination and Adverse Outcomes, 2003-2004. Clin Infect Dis; 46 (Suppl 3): S271-S293; March 15, 2008. VAERS

14. Chapman, L. E.; Mootrey, G. T.; Neff, L. J. Introduction: Vaccination Against Smallpox in the Posteradication Era. Clin Infect Dis; 46 (Suppl 3): S153-S156; March 15, 2008.

15. Chudasama, R. K. Evaluation of Intensive Pulse Polio Immunization in District Valsad During 2007. Indian Pediatr; 45 (3): 233-235; March 7, 2008.

16. Clements, C. J.; Nshimirimanda, D.; Gasasira, A. Using Immunization Delivery Strategies to Accelerate Progress in Africa Towards Achieving the Millennium Development Goals. Vaccine; 26 (16): 1926-1933; April 7, 2008.

17. Colombo, G. L.; Ferro, A.; Vinci, M.; Zordan, M.; Serra, G. Cost-Benefit Analysis of Influenza Vaccination in a Public Healthcare Unit. Ther Clin Risk Manag; 2 (2): 219-226; June, 2006.

18. Constenla, D.; Ortega-Barria, E.; Rheingans, R. D.; Antil, L.; Saez-Llorens, X. [Economic Impact of Rotavirus Vaccination in Panama.]. An Pediatr (Barc ); 68 (2): 128-135; February, 2008.

19. Cortese, M. M.; Baughman, A. L.; Zhang, R.; Srivastava, P. U.; Wallace, G. S. Pertussis Hospitalizations Among Infants in the United States, 1993 to 2004. Pediatrics; 121 (3): 484-492; March, 2008.

20. Del Rio Camacho, G.; Perea-Milla Lopez, E.; Romero Gonzalez, J.; Gonzalez Canoniga, A.; Munumel Alameda, B.; Martin Cabello, O.; Martinez Collado, M.; Perez Frias, J. Prevalence of Tuberculosis Infection in BCG-Vaccinated and Unvaccinated Mediterranean Schoolchildren. Arch Bronconeumol; 44 (2): 75-80; February, 2008.

21. Dibonaventura, M. D.; Chapman, G. B. Do Decision Biases Predict Bad Decisions? Omission Bias, Naturalness Bias, and Influenza Vaccination. Med Decis Making; March 4, 2008. [Epub ahead of print].

22. Duintjer Tebbens, R. J.; Thompson, K. M.; Hunink, M. G.; Mazzuchi, T. A.; Lewandowski, D.; Kurowicka, D.; Cooke, R. M. Uncertainty and Sensitivity Analyses of a Dynamic Economic Evaluation Model for Vaccination Programs. Med Decis Making; 28 (2): 182-200; March, 2008.

23. France, E. K.; Glanz, J.; Xu, S.; Hambidge, S.; Yamasaki, K.; Black, S. B.; Marcy, M.; Mullooly, J. P.; Jackson, L. A.; Nordin, J.; Belongia, E. A.; Hohman, K.; Chen, R. T.; Davis, R. Risk of Immune Thrombocytopenic Purpura After Measles-Mumps-Rubella Immunization in Children. Pediatrics; 121 (3): e687-e692; March, 2008.

24. Francis, P. T. Maternal Vaccination Against Pertussis. Lancet Infect Dis; 8 (4): 214; April, 2008.

25. Gai, W.; Zou, W.; Lei, L.; Luo, J.; Tu, H.; Zhang, Y.; Wang, K.; Tien, P.; Yan, H. Effects of Different Immunization Protocols and Adjuvant on Antibody Responses to Inactivated SARS-CoV Vaccine. Viral Immunol; 21 (1): 27-37; March, 2008.

26. Gao, S.; Teng, Z.; Nieto, J. J.; Torres, A. Analysis of an SIR Epidemic Model With Pulse Vaccination and Distributed Time Delay. J Biomed Biotechnol; 2007: 64870; 2007.

27. Grgic-Vitek, M.; Klavs, I.; Kraigher, A. Re-Emergence of Pertussis in Slovenia: Time to Change Immunization Policy. Vaccine; 26 (15): 1874-1878; March 28, 2008.

28. Hampton, T. Research Reveals Low Immunization Rates and Vaccination Awareness Among Adults. JAMA; 299 (9): 1007; March 5, 2008.

29. Havli, J. [The Importance of Pneumococcal Vaccination - a Clinician's View.]. Klin Mikrobiol Infekc Lek; 14 (1): 30-35; February, 2008.

30. Hayanga, A. J.; Kaiser, H. E. Medical Information on YouTube. JAMA; 299 (12): 1424-1425; March 26, 2008.

31. Hoshi, S. L.; Kondo, M.; Okubo, I. [Study on Pricing and Uptake Rate of Influenza Vaccination for the Elderly in Japan With a Simple Random Sampling Method]. Nippon Koshu Eisei Zasshi; 55 (1): 19-29; January, 2008.

32. Jackson, L. A.; Starkovich, P.; Dunstan, M.; Yu, O.; Nelson, J.; Dunn, J.; Rees, T.; Zavitkovsky, A.; Maus, D.; Froeschle, J. E.; Decker, M. Prospective Assessment of the Effect of Needle Length and Injection Site on the Risk of Local Reactions to the Fifth Diphtheria-Tetanus-Acellular Pertussis Vaccination. Pediatrics; 121 (3): e646-e652; March, 2008.

33. Kahng, J.; Lee, H. J. [Clinical Efficacy of HPV DNA Chip Test in the Era of HPV Vaccination: 1,211 Cases, A Single Institution Study.]. Korean J Lab Med; 28 (1): 70-78; February, 2008.

34. Kalies, H.; Redel, R.; Varga, R.; Tauscher, M.; von, Kries R. Vaccination Coverage in Children Can Be Estimated From Health Insurance Data. BMC Public Health; 8: 82; March 1, 2008.

35. Kasten, M. J.; Poland, G. A. Influenza Vaccination and the Elderly : Pandemic Preparedness. Drugs Aging; 25 (3): 179-186; 2008.

36. Keshtkar-Jahromi, M.; Argani, H.; Rahnavardi, M.; Mirchi, E.; Atabak, S.; Tara, S. A.; Gachkar, L.; Noori-Froothghe, A.; Mokhtari-Azad, T. Antibody Response to Influenza Immunization in Kidney Transplant Recipients Receiving Either Azathioprine or Mycophenolate: A Controlled Trial. Am J Nephrol; 28 (4): 654-660; March 6, 2008.

37. Khan, M. M. Economics of Polio Vaccination in the Post-Eradication Era: Should OPV-Using Countries Adopt IPV? Vaccine; 26 (16): 2034-2040; April 7, 2008.

38. Klein, N. P.; Massolo, M. L.; Greene, J.; Dekker, C. L.; Black, S.; Escobar, G. J. Risk Factors for Developing Apnea After Immunization in the Neonatal Intensive Care Unit. Pediatrics; 121 (3): 463-469; March, 2008.

39. Kroger, A.; Vellozzi, C.; Deming, M.; Casey, C. G.; Wen, X.; Norton, S. A. Dermatological Lesions Near the Smallpox Vaccination Site After Scab Detachment. Clin Infect Dis; 46 (Suppl 3): S227-S233; March 15, 2008.

40. Kumar, D.; Manuel, O.; Humar, A. Response to: Larger Dose of Intradermal Influenza Vaccination May Be More Immunogenic in Transplant Recipients. Am J Transplant; 2008 Feb 29 [Epub ahead of print].

41. Laguna, C.; Martinez, L.; Sanchez, J. L.; Alegre, V. Squamous Cell Carcinoma at Tetanus Vaccination Site. J Eur Acad Dermatol Venereol; 2008 Mar 7 [Epub ahead of print].

42. Lahdenpera, A. I.; Nilsson, L. J.; Regnstrom, K. Kinetics of Asthma- and Allergy-Associated Immune Response Gene Expression in Peripheral Blood Mononuclear Cells From Vaccinated Infants After in Vitro Re-Stimulation With Vaccine Antigen. Vaccine; 26 (14): 1725-1730; March 25, 2008.

43. Lennon, D. The Role of MeNZB Vaccination in Controlling the New Zealand Meningococcal Epidemic. N Z Med J; 121 (1270): 110-112; March 14, 2008.

44. Lin, M. Y.; Ottenhoff, T. H. Not to Wake a Sleeping Giant: New Insights into Host-Pathogen Interactions Identify New Targets for Vaccination Against Latent Mycobacterium Tuberculosis Infection. Biol Chem; March 6, 2008. [Epub ahead of print].

45. Lippman, A.; Boscoe, M.; Scurfield, C. Rebuttal: Do You Approve of Spending $300 Million on HPV Vaccination? No. Can Fam Physician; 54 (3): 343, 345; March, 2008.

46. Lu, P.; Bridges, C. B.; Euler, G. L.; Singleton, J. A. Influenza Vaccination of Recommended Adult Populations, U.S., 1989-2005. Vaccine; 26 (14): 1786-1793; March 25, 2008.

47. Luman, E. T.; Sablan, M.; Stokley, S.; McCauley, M. M.; Shaw, K. M. Impact of Methodological 'Shortcuts' in Conducting Public Health Surveys: Results From a Vaccination Coverage Survey. BMC Public Health; 8 (1): 99; March 27, 2008.

48. Mahmoud, A.; Levin, M. Vaccines at the Turn of the 21st Century: a New Era for Immunization in Public Health. Int J Infect Dis; 11 (Suppl 2): S1-S2; November, 2007.

49. Maltezou, H. C.; Maragos, A.; Katerelos, P.; Paisi, A.; Karageorgou, K.; Papadimitriou, T.; Pierroutsakos, I. N. Influenza Vaccination Acceptance Among Health-Care Workers: A Nationwide Survey. Vaccine; 26 (11): 1408-1410; March 10, 2008.

50. Mangrio, N. K.; Alam, M. M.; Shaikh, B. T. Is Expanded Programme on Immunization Doing Enough? Viewpoint of Health Workers and Managers in Sindh, Pakistan. J Pak Med Assoc; 58 (2): 64-67; February, 2008.

51. Mathew, J. L. Universal Pneumococcal Vaccination for India. Indian Pediatr; 45 (2): 160-161; February, 2008.

52. Mishra, A.; Mishra, R. Universal Pneumococcal Vaccination in India: Is It a Priority? Indian Pediatr; 45 (2): 161-162; February, 2008.

53. Mooi, F. R.; de Greeff, S. C. Maternal Vaccination Against Pertussis - Authors' Reply. Lancet Infect Dis; 8 (4): 214-215; April, 2008.

54. Morgan, J.; Roper, M. H.; Sperling, L.; Schieber, R. A.; Heffelfinger, J. D.; Casey, C. G.; Miller, J. W.; Santibanez, S.; Herwaldt, B.; Hightower, P.; Moro, P. L.; Hibbs, B. F.; Levine, N. H.; Chapman, L. E.; Iskander, J.; Lane, J. M.; Wharton, M.; Mootrey, G. T.; Swerdlow, D. L. Myocarditis, Pericarditis, and Dilated Cardiomyopathy After Smallpox Vaccination Among Civilians in the United States, January-October 2003. Clin Infect Dis; 46 (Suppl 3): S242-S250; March 15, 2008. VAERS

55. Mossad, S. B. Larger Dose of Intradermal Influenza Vaccination May Be More Immunogenic in Transplant Recipients. Am J Transplant; 2008 March 2 [Epub ahead of print].

56. Nakajima, H.; Kariya, H.; Ohata, R.; Ogura, H. Investigation of Immunity Level Against Diphtheria and Reinforcement of Immunity by Booster Vaccination for Infection Control Staff in Okayama Prefecture. Jpn J Infect Dis; 61 (2): 104-106; March, 2008.

57. Neff, J.; Modlin, J.; Birkhead, G. S.; Poland, G.; Robertson, R. M.; Sepkowitz, K.; Yancy, C.; Gardner, P.; Gray, G. C.; Maurer, T.; Siegel, J.; Guerra, F. A.; Berger, T.; Flanders, W. D.; Shope, R. Monitoring the Safety of a Smallpox Vaccination Program in the United States: Report of the Joint Smallpox Vaccine Safety Working Group of the Advisory Committee on Immunization Practices and the Armed Forces Epidemiological Board. Clin Infect Dis; 46 (Suppl 3): S258-S270; March 15, 2008.

58. Newall, A. T.; Scuffham, P. A.; Kelly, H.; Harsley, S.; Macintyre, C. R. The Cost-Effectiveness of a Universal Influenza Vaccination Program for Adults Aged 50-64 Years in Australia. Vaccine; 26(17): 2142-2153; February, 2008.

59. Ochoa-Gondar, O.; Vila-Corcoles, A.; Ansa, X.; Rodriguez-Blanco, T.; Salsench, E.; de, Diego C.; Raga, X.; Gomez, F.; Valdivieso, E.; Fuentes, C.; Palacios, L. Effectiveness of Pneumococcal Vaccination in Older Adults With Chronic Respiratory Diseases: Results of the EVAN-65 Study. Vaccine; 26 (16): 1955-1962; April 7, 2008.

60. Ortega-Sanchez, I. R.; Sniadack, M. M.; Mootrey, G. T. Economics of Cardiac Adverse Events After Smallpox Vaccination: Lessons From the 2003 US Vaccination Program. Clin Infect Dis; 46 (Suppl 3): S168-S178; March 15, 2008.

61. Parikh, R. K. Fighting for the Reputation of Vaccines: Lessons From American Politics. Pediatrics; 121 (3): 621-622; March, 2008.

62. Rashid, H.; Shafi, S.; Haworth, E.; Booy, R. Pneumococcal Vaccination in Adults. Arch Intern Med; 168 (6): 666-667; March 24, 2008.

63. Rendi-Wagner, P.; Paulke-Korinek, M.; Kundi, M.; Wiedermann, U.; Laaber, B.; Kollaritsch, H. Seroprotection 4 Years Following Booster Vaccination Against Tick-Borne Encephalitis. Int J Med Microbiol; March 5, 2008. [Epub ahead of print].

64. Riddle, M. S.; Patel, S. S.; Sanders, J. W.; Armstrong, A. W.; Putnam, S. D.; Schlett, C. D.; Tribble, D. R. Attitudes Toward Predeployment and Experimental Vaccinations Among Troops Deployed to Operation Iraqi Freedom and Operation Enduring Freedom. J Travel Med; 15 (2): 68-76; March, 2008.

65. Romanowska, M.; Rybicka, K.; Nowak, I.; Jozefczuk, J.; Zycinska, K.; Radzikowski, A.; Brydak, L. B. Antibody Response to Influenza Vaccination in Patients Suffering From Asthma. J Physiol Pharmacol; 58 (Suppl 5-Pt2): 583-589; November, 2007.

66. Ruiz-Rodriguez, M.; Vera-Cala, L. M.; Lopez-Barbosa, N. [Health Insurance for Infants and Infant Vaccination Related to Forced-Displacement in Colombia.]. Rev Salud Publica (Bogota ); 10 (1): 49-61; January, 2008.

67. Samuelsson, O.; Herlitz, H. Vaccination Against High Blood Pressure: a New Strategy. Lancet; 371 (9615): 788-789; March 8, 2008.

68. Senior, K. Global Aspirations for HPV Vaccination. Lancet Infect Dis; 8 (3): 150; March, 2008.

69. Smith, P. J.; Stevenson, J. Racial/Ethnic Disparities in Vaccination Coverage by 19 Months of Age: An Evaluation of the Impact of Missing Data Resulting From Record Scattering. Stat Med; March 14, 2008. [Epub ahead of print].

70. Sniadack, M. M.; Neff, L. J.; Swerdlow, D. L.; Schieber, R. A.; McCauley, M. M.; Mootrey, G. T. Follow-Up of Cardiovascular Adverse Events After Smallpox Vaccination Among Civilians in the United States, 2003. Clin Infect Dis; 46 (Suppl 3): S251-S257; March 15, 2008.

71. Steben, M. Rebuttal: Do You Approve of Spending $300 Million on HPV Vaccination? Yes. Can Fam Physician; 54 (3): 342, 344; March, 2008.

72. Suraratdecha, C.; Ramana, C. V.; Kaipilyawar, S.; Krishnamurthy; Sivalenka, S.; Ambatipudi, N.; Gandhi, S.; Umashankar, K.; Cheyne, J. Cost and Effectiveness Analysis of Immunization Service Delivery Support in Andhra Pradesh, India. Bull World Health Organ; 86 (3): 221-228; March, 2008.

73. Swerdlow, D. L.; Roper, M. H.; Morgan, J.; Schieber, R. A.; Sperling, L. S.; Sniadack, M. M.; Neff, L.; Miller, J. W.; Curtis, C. R.; Marin, M. E.; Iskander, J.; Moro, P.; Hightower, P.; Levine, N. H.; McCauley, M.; Heffelfinger, J.; Damon, I.; Torok, T. J.; Wharton, M.; Mast, E. E.; Mootrey, G. T. Ischemic Cardiac Events During the Department of Health and Human Services Smallpox Vaccination Program, 2003. Clin Infect Dis; 46 (Suppl 3); March 15, 2008.

74. Tjelle, T. E.; Rabussay, D.; Ottensmeier, C.; Mathiesen, I.; Kjeken, R. Taking Electroporation-Based Delivery of DNA Vaccination into Humans: a Generic Clinical Protocol. Methods Mol Biol; 423: 497-507; 2008.

75. Uskun, E.; Uskun, S. B.; Uysalgenc, M.; Yagiz, M. Effectiveness of a Training Intervention on Immunization to Increase Knowledge of Primary Healthcare Workers and Vaccination Coverage Rates. Public Health; February 28, 2008. [Epub ahead of print].

76. Vandelaer, J.; Bilous, J.; Nshimirimana, D. Reaching Every District (RED) Approach: a Way to Improve Immunization Performance. Bull World Health Organ; 86 (3): A-B; March, 2008.

77. Wiesik-Szewczyk, E.; Lacki, J. K.; Chwaliniska-Sadowska, H. [Should We Vaccinate Patients With Systemic Lupus]. Pol Merkur Lekarski; 23 (137): 395-398; November, 2007.

78. Wilder-Smith, A.; Hill, D. R.; Freedman, D. O. The Revised International Health Regulations (2005): Impact on Yellow Fever Vaccination in Clinical Practice. Am J Trop Med Hyg; 78 (3): 359-360; March, 2008.

79. Woodland, D. L. Vaccination Strategies. Viral Immunol; 21 (1): 1-2; March, 2008.